359 related articles for article (PubMed ID: 14640983)
41. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C.
Torgeman A; Mor-Vaknin N; Zelin E; Ben-Aroya Z; Löchelt M; Flügel RM; Aboud M
Virology; 2001 Mar; 281(1):10-20. PubMed ID: 11222091
[TBL] [Abstract][Full Text] [Related]
42. Human herpesvirus 6B induces phosphorylation of p53 in its regulatory domain by a CK2- and p38-independent pathway.
Øster B; Bundgaard B; Hupp TR; Höllsberg P
J Gen Virol; 2008 Jan; 89(Pt 1):87-96. PubMed ID: 18089732
[TBL] [Abstract][Full Text] [Related]
43. Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2.
Schuster N; Prowald A; Schneider E; Scheidtmann KH; Montenarh M
FEBS Lett; 1999 Mar; 447(2-3):160-6. PubMed ID: 10214938
[TBL] [Abstract][Full Text] [Related]
44. Protein kinase CK2 interacts with a multi-protein binding domain of p53.
Götz C; Scholtes P; Prowald A; Schuster N; Nastainczyk W; Montenarh M
Mol Cell Biochem; 1999 Jan; 191(1-2):111-20. PubMed ID: 10094399
[TBL] [Abstract][Full Text] [Related]
45. Alternative binding modes of an inhibitor to two different kinases.
De Moliner E; Brown NR; Johnson LN
Eur J Biochem; 2003 Aug; 270(15):3174-81. PubMed ID: 12869192
[TBL] [Abstract][Full Text] [Related]
46. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.
Homma MK; Li D; Krebs EG; Yuasa Y; Homma Y
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5959-64. PubMed ID: 11972058
[TBL] [Abstract][Full Text] [Related]
47. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.
Hjerrild M; Milne D; Dumaz N; Hay T; Issinger OG; Meek D
Biochem J; 2001 Apr; 355(Pt 2):347-56. PubMed ID: 11284721
[TBL] [Abstract][Full Text] [Related]
48. Protein kinase CK2 phosphorylates and interacts with deoxyhypusine synthase in HeLa cells.
Kang KR; Chung SI
Exp Mol Med; 2003 Dec; 35(6):556-64. PubMed ID: 14749535
[TBL] [Abstract][Full Text] [Related]
49. Wild-type p53 inhibits protein kinase CK2 activity.
Schuster N; Götz C; Faust M; Schneider E; Prowald A; Jungbluth A; Montenarh M
J Cell Biochem; 2001; 81(1):172-83. PubMed ID: 11180407
[TBL] [Abstract][Full Text] [Related]
50. Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells.
Sinha R; Kiley SC; Lu JX; Thompson HJ; Moraes R; Jaken S; Medina D
Cancer Lett; 1999 Nov; 146(2):135-45. PubMed ID: 10656618
[TBL] [Abstract][Full Text] [Related]
51. CHOP transcription factor phosphorylation by casein kinase 2 inhibits transcriptional activation.
Ubeda M; Habener JF
J Biol Chem; 2003 Oct; 278(42):40514-20. PubMed ID: 12876286
[TBL] [Abstract][Full Text] [Related]
52. U.V.C.-induction of p53 activation and accumulation is dependent on cell cycle and pathways involving protein synthesis and phosphorylation.
Pitkänen K; Haapajärvi T; Laiho M
Oncogene; 1998 Jan; 16(4):459-69. PubMed ID: 9484835
[TBL] [Abstract][Full Text] [Related]
53. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
Craig AL; Burch L; Vojtesek B; Mikutowska J; Thompson A; Hupp TR
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):133-41. PubMed ID: 10432310
[TBL] [Abstract][Full Text] [Related]
54. p21WAF1/CIP1 interacts with protein kinase CK2.
Götz C; Wagner P; Issinger OG; Montenarh M
Oncogene; 1996 Jul; 13(2):391-8. PubMed ID: 8710378
[TBL] [Abstract][Full Text] [Related]
55. Contribution of protein kinase C to p53-dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines.
Ohnishi K; Wang X; Takahashi A; Ohnishi T
Exp Cell Res; 1998 Feb; 238(2):399-406. PubMed ID: 9473348
[TBL] [Abstract][Full Text] [Related]
56. The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.
Retzlaff M; Rohrberg J; Küpper NJ; Lagleder S; Bepperling A; Manzenrieder F; Peschek J; Kessler H; Buchner J
J Mol Biol; 2013 Jan; 425(1):144-55. PubMed ID: 23103206
[TBL] [Abstract][Full Text] [Related]
57. Cyclin-dependent kinase 11p110 and casein kinase 2 (CK2) inhibit the interaction between tyrosine hydroxylase and 14-3-3.
Sachs NA; Vaillancourt RR
J Neurochem; 2004 Jan; 88(1):51-62. PubMed ID: 14675149
[TBL] [Abstract][Full Text] [Related]
58. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome.
Uhle S; Medalia O; Waldron R; Dumdey R; Henklein P; Bech-Otschir D; Huang X; Berse M; Sperling J; Schade R; Dubiel W
EMBO J; 2003 Mar; 22(6):1302-12. PubMed ID: 12628923
[TBL] [Abstract][Full Text] [Related]
59. The in vitro phosphorylation of p53 by calcium-dependent protein kinase C--characterization of a protein-kinase-C-binding site on p53.
Delphin C; Huang KP; Scotto C; Chapel A; Vincon M; Chambaz E; Garin J; Baudier J
Eur J Biochem; 1997 May; 245(3):684-92. PubMed ID: 9183006
[TBL] [Abstract][Full Text] [Related]
60. Recognition of DNA modified by antitumor cisplatin by "latent" and "active" protein p53.
Fojta M; Pivonkova H; Brazdova M; Kovarova L; Palecek E; Pospisilova S; Vojtesek B; Kasparkova J; Brabec V
Biochem Pharmacol; 2003 Apr; 65(8):1305-16. PubMed ID: 12694871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
